CIK 0002023658
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Bicara Therapeutics Inc.
Sign in to watch- Ticker
- BCAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-468-4219
- Business address
- 116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $400,716
- in 1 filing, $401K under 10b5-1 plans
Net −$400,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-09 | Haviland Kate Director | Grant or award · Stock Option (Right to Buy) | +19,475 | 19,475 | ||
| 2025-06-09 | Haviland Kate Director | Grant or award · Stock Option (Right to Buy) | +23,746 | 23,746 | ||
| 2024-09-12 | Haviland Kate Director | Grant or award · Stock Option (Right to Buy) | +23,746 | 23,746 |
Page 1 of 1 · 3 trades